Search

Donna J. Ricks

Examiner (ID: 140, Phone: (571)270-7532 , Office: P/2612 )

Most Active Art Unit
2612
Art Unit(s)
2679, 2612, 2618, 2628, 2677
Total Applications
602
Issued Applications
434
Pending Applications
57
Abandoned Applications
118

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17419539 [patent_doc_number] => 11252965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-22 [patent_title] => RNAi insecticide materials and methods [patent_app_type] => utility [patent_app_number] => 16/316847 [patent_app_country] => US [patent_app_date] => 2017-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17304 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16316847 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/316847
RNAi insecticide materials and methods Jul 12, 2017 Issued
Array ( [id] => 14897547 [patent_doc_number] => 20190292539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-26 [patent_title] => METHOD FOR MODIFYING GENES [patent_app_type] => utility [patent_app_number] => 16/316764 [patent_app_country] => US [patent_app_date] => 2017-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11293 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16316764 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/316764
Method for modifying genes Jul 12, 2017 Issued
Array ( [id] => 14963631 [patent_doc_number] => 20190309294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-10 [patent_title] => PROCESS OF DELIVERING SMALL RNAS TO SPERM [patent_app_type] => utility [patent_app_number] => 16/315004 [patent_app_country] => US [patent_app_date] => 2017-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21327 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -135 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315004 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/315004
Process of delivering small RNAs to sperm Jul 11, 2017 Issued
Array ( [id] => 17280923 [patent_doc_number] => 11197936 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-14 [patent_title] => Methods and compositions for treatment of disorders and diseases involving RDH12 [patent_app_type] => utility [patent_app_number] => 16/314179 [patent_app_country] => US [patent_app_date] => 2017-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 27 [patent_no_of_words] => 19692 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16314179 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/314179
Methods and compositions for treatment of disorders and diseases involving RDH12 Jul 6, 2017 Issued
Array ( [id] => 15210461 [patent_doc_number] => 20190367917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-05 [patent_title] => DIAGNOSING COL6-RELATED DISORDERS AND METHODS FOR TREATING SAME [patent_app_type] => utility [patent_app_number] => 16/315278 [patent_app_country] => US [patent_app_date] => 2017-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19443 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315278 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/315278
Diagnosing COL6-related disorders and methods for treating same Jul 4, 2017 Issued
Array ( [id] => 12157289 [patent_doc_number] => 20180028554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-01 [patent_title] => 'Oligomers Having Bicyclic Scaffold Moeities' [patent_app_type] => utility [patent_app_number] => 15/642270 [patent_app_country] => US [patent_app_date] => 2017-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 43695 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15642270 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/642270
Oligomers Having Bicyclic Scaffold Moeities Jul 4, 2017 Abandoned
Array ( [id] => 14747365 [patent_doc_number] => 20190256856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-22 [patent_title] => METHODS OF MODULATING MELANOSOME PH AND MELANIN LEVEL IN CELLS [patent_app_type] => utility [patent_app_number] => 16/314203 [patent_app_country] => US [patent_app_date] => 2017-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15401 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16314203 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/314203
Methods of modulating melanosome pH and melanin level in cells Jun 29, 2017 Issued
Array ( [id] => 11994207 [patent_doc_number] => 20170298362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'ANTI-TUMOR THERAPY' [patent_app_type] => utility [patent_app_number] => 15/636952 [patent_app_country] => US [patent_app_date] => 2017-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15832 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15636952 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/636952
ANTI-TUMOR THERAPY Jun 28, 2017 Abandoned
Array ( [id] => 12119115 [patent_doc_number] => 20180002702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-04 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING MALIGNANT TUMORS ASSOCIATED WITH KRAS MUTATION' [patent_app_type] => utility [patent_app_number] => 15/636528 [patent_app_country] => US [patent_app_date] => 2017-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 20612 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15636528 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/636528
METHODS AND COMPOSITIONS FOR TREATING MALIGNANT TUMORS ASSOCIATED WITH KRAS MUTATION Jun 27, 2017 Abandoned
Array ( [id] => 17075117 [patent_doc_number] => 11111503 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-07 [patent_title] => Method for expressing protein gene in response to expression of miRNA [patent_app_type] => utility [patent_app_number] => 16/313322 [patent_app_country] => US [patent_app_date] => 2017-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10902 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313322 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/313322
Method for expressing protein gene in response to expression of miRNA Jun 26, 2017 Issued
Array ( [id] => 15020945 [patent_doc_number] => 20190321477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-24 [patent_title] => METHODS AND COMPOSITIONS RELATED TO CHITOSAN-DERIVED NANOPARTICLE-MEDIATED CRISPR/CAS9 DELIVERY [patent_app_type] => utility [patent_app_number] => 16/313255 [patent_app_country] => US [patent_app_date] => 2017-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9393 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313255 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/313255
METHODS AND COMPOSITIONS RELATED TO CHITOSAN-DERIVED NANOPARTICLE-MEDIATED CRISPR/CAS9 DELIVERY Jun 26, 2017 Abandoned
Array ( [id] => 13703287 [patent_doc_number] => 20170362598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => ANTICANCER THERAPEUTIC INTERVENTION [patent_app_type] => utility [patent_app_number] => 15/622859 [patent_app_country] => US [patent_app_date] => 2017-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25339 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15622859 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/622859
Anticancer therapeutic intervention Jun 13, 2017 Issued
Array ( [id] => 16399153 [patent_doc_number] => 20200340011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-29 [patent_title] => RECOMBINANT INSECT VECTORS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 16/308076 [patent_app_country] => US [patent_app_date] => 2017-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9280 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308076 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/308076
RECOMBINANT INSECT VECTORS AND METHODS OF USE Jun 11, 2017 Abandoned
Array ( [id] => 14277913 [patent_doc_number] => 20190136241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-09 [patent_title] => APTAMER-BASED ANALYTE ASSAYS [patent_app_type] => utility [patent_app_number] => 16/306485 [patent_app_country] => US [patent_app_date] => 2017-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44513 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16306485 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/306485
APTAMER-BASED ANALYTE ASSAYS Jun 4, 2017 Abandoned
Array ( [id] => 15102755 [patent_doc_number] => 10472681 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-12 [patent_title] => miRNA-based universal screening test (UST) [patent_app_type] => utility [patent_app_number] => 15/606747 [patent_app_country] => US [patent_app_date] => 2017-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 75 [patent_figures_cnt] => 148 [patent_no_of_words] => 24856 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 253 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15606747 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/606747
miRNA-based universal screening test (UST) May 25, 2017 Issued
Array ( [id] => 12656866 [patent_doc_number] => 20180110788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-26 [patent_title] => METHODS AND COMPOSITIONS FOR INHIBITING THE GROWTH AND/OR PROLIFERATION OF MYC-DRIVEN TUMOR CELLS [patent_app_type] => utility [patent_app_number] => 15/604993 [patent_app_country] => US [patent_app_date] => 2017-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7678 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15604993 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/604993
METHODS AND COMPOSITIONS FOR INHIBITING THE GROWTH AND/OR PROLIFERATION OF MYC-DRIVEN TUMOR CELLS May 24, 2017 Abandoned
Array ( [id] => 16843122 [patent_doc_number] => 11015196 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-05-25 [patent_title] => Using microRNAs to control activation status of hepatic stellate cells and to prevent fibrosis in progressive liver diseases [patent_app_type] => utility [patent_app_number] => 16/302940 [patent_app_country] => US [patent_app_date] => 2017-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 19 [patent_no_of_words] => 29363 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302940 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/302940
Using microRNAs to control activation status of hepatic stellate cells and to prevent fibrosis in progressive liver diseases May 18, 2017 Issued
Array ( [id] => 14747313 [patent_doc_number] => 20190256830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-22 [patent_title] => METHOD FOR CELL-SPECIFICALLY CONTROLLING NUCLEASE [patent_app_type] => utility [patent_app_number] => 16/313328 [patent_app_country] => US [patent_app_date] => 2017-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15806 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313328 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/313328
METHOD FOR CELL-SPECIFICALLY CONTROLLING NUCLEASE May 17, 2017 Abandoned
Array ( [id] => 14716219 [patent_doc_number] => 20190249173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS [patent_app_type] => utility [patent_app_number] => 16/098658 [patent_app_country] => US [patent_app_date] => 2017-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 206058 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098658 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/098658
METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS May 2, 2017 Abandoned
15/584728 Amplification of oligonucleotides containing non-standard nucleotides May 1, 2017 Abandoned
Menu